Available datapackage for study 'Risperidone Versus Haloperidol Versus Placebo in the Treatment of Chronic Schizophrenia'
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00004669.0
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of the study is to evaluate the effectiveness and safety of different doses of risperidone (an antipsychotic medication) compared with placebo and with a fixed 20 mg/day dose of a standard antipsychotic, haloperidol, in patients with chronic schizophrenia.
提供机构：
Vivli
创建时间：
2024-04-15
